Clinical Trials Logo

Clinical Trial Summary

This study compares two treatments for Idiopathic Esophagogastric Junction Outflow Obstruction: pneumatic dilation compared with expectant management, on symptoms and liquid barium emptying exams.


Clinical Trial Description

The objectives of this study are to address these gaps in knowledge by: Performing a randomized controlled trial in patients with idiopathic EGJOO that compares treatment outcomes after pneumatic dilation versus expectant management (disease controls) (expectant management). And, determining rational physiological and objective measures of treatment response. ;


Study Design


Related Conditions & MeSH terms

  • Esophagogastric Junction Disorder

NCT number NCT04096703
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Withdrawn
Phase N/A
Start date October 2021
Completion date February 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05161572 - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Phase 2
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Not yet recruiting NCT03961841 - Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma Phase 3
Recruiting NCT04923932 - Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients Phase 2
Not yet recruiting NCT04938102 - Role of EndoFLIP in the Diagnostic Paradigm of Esophagogastric Junction Outflow Obstruction N/A
Recruiting NCT04455282 - CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
Recruiting NCT03909997 - Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer